Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 684

1.

New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.

Stefanelli T, Malesci A, Repici A, Vetrano S, Danese S.

Curr Drug Targets. 2008 May;9(5):413-8. Review.

PMID:
18473770
2.

Etiology and pathogenesis of inflammatory bowel disease.

Schmidt C, Stallmach A.

Minerva Gastroenterol Dietol. 2005 Jun;51(2):127-45. Review.

PMID:
15990703
3.

Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights.

Zois CD, Katsanos KH, Kosmidou M, Tsianos EV.

J Crohns Colitis. 2010 Jun;4(2):115-24. doi: 10.1016/j.crohns.2009.10.005. Epub 2009 Dec 3. Review.

4.

Biologic therapy for inflammatory bowel disease.

Ardizzone S, Bianchi Porro G.

Drugs. 2005;65(16):2253-86. Review.

PMID:
16266194
5.

Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

Sartor RB.

Gastroenterol Clin North Am. 1995 Sep;24(3):475-507. Review.

PMID:
8809232
6.

Recent understanding of IBD pathogenesis: implications for future therapies.

Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S, Domschke W.

Inflamm Bowel Dis. 2006 Nov;12(11):1068-83. Review.

PMID:
17075348
7.

New pathophysiological insights and modern treatment of IBD.

Engel MA, Neurath MF.

J Gastroenterol. 2010 Jun;45(6):571-83. doi: 10.1007/s00535-010-0219-3. Epub 2010 Mar 9. Review.

PMID:
20213337
8.

[Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy)].

Jantchou P, Monnet E, Carbonnel F.

Gastroenterol Clin Biol. 2006 Jun-Jul;30(6-7):859-67. Review. French.

9.

Pharmacotherapeutic options in inflammatory bowel disease: an update.

Kho YH, Pool MO, Jansman FG, Harting JW.

Pharm World Sci. 2001 Feb;23(1):17-21. Review.

PMID:
11344586
10.

Current pharmacotherapy for inflammatory bowel disease.

McKaig BC, Stack WA.

Expert Opin Pharmacother. 1999 Nov;1(1):3-14. Review.

PMID:
11249561
11.

Current therapeutic approaches in inflammatory bowel disease.

Sohrabpour AA, Malekzadeh R, Keshavarzian A.

Curr Pharm Des. 2010;16(33):3668-83.

PMID:
21128898
12.

Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey.

Sung JJ, Kamm MA, Marteau P.

J Gastroenterol Hepatol. 2010 Jan;25(1):183-93. doi: 10.1111/j.1440-1746.2009.06024.x. Epub 2009 Nov 19.

PMID:
19929931
13.

News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.

Latella G, Fiocchi C, Caprili R.

J Crohns Colitis. 2010 Dec;4(6):690-702. doi: 10.1016/j.crohns.2010.08.002. Epub 2010 Oct 8.

14.

[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].

Ochsenkühn T, Sackmann M, Göke B.

Radiologe. 2003 Jan;43(1):1-8. Review. German.

PMID:
12552369
15.

Chemokines in inflammatory bowel disease.

Papadakis KA.

Curr Allergy Asthma Rep. 2004 Jan;4(1):83-9. Review.

PMID:
14680627
16.

State of the art: IBD therapy and clinical trials in IBD.

Isaacs KL, Lewis JD, Sandborn WJ, Sands BE, Targan SR.

Inflamm Bowel Dis. 2005 Nov;11 Suppl 1:S3-12. Review.

PMID:
16254481
17.

[Conservative therapy of inflammatory bowel diseases].

Nagy F.

Orv Hetil. 2002 Dec 15;143(50):2763-8. Review. Hungarian.

PMID:
12583315
18.

Inflammatory bowel disease: progress and current concepts of etiopathogenesis.

Scaldaferri F, Fiocchi C.

J Dig Dis. 2007 Nov;8(4):171-8. Review.

PMID:
17970872
19.
20.

Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine.

Goyette P, Labbé C, Trinh TT, Xavier RJ, Rioux JD.

Ann Med. 2007;39(3):177-99. Review.

PMID:
17457716
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk